Hypermarcas (OTCMKTS:HYPMY) Trading Down 4.3% - What's Next?

Key Points

• Hypermarcas's stock price decreased by 4.3% to $4.40, with trading volume significantly down at 1,782 shares compared to the average of 68,639 shares.
• Wall Street analysts maintain a strong-buy rating for Hypermarcas, indicating positive sentiment towards the stock despite its recent price drop.
• The company announced a dividend of $0.0345 per share, reflecting a yield of 281.0%, with the payment scheduled for January 8th.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report)'s share price was down 4.3% on Wednesday . The company traded as low as $4.30 and last traded at $4.40. Approximately 1,782 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 68,639 shares. The stock had previously closed at $4.60.

Analyst Upgrades and Downgrades

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research report on Thursday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, Hypermarcas has a consensus rating of "Strong Buy".

Hypermarcas Price Performance

The stock has a market cap of $2.87 billion, a price-to-earnings ratio of 21.55 and a beta of 0.86. The company has a quick ratio of 0.80, a current ratio of 1.26 and a debt-to-equity ratio of 0.63. The company's 50-day moving average is $4.45 and its 200-day moving average is $4.20.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Dividend Announcement

The firm also recently announced a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be given a $0.0345 dividend. This represents a yield of 281.0%. The ex-dividend date is Monday, June 30th. Hypermarcas's dividend payout ratio (DPR) is presently 57.14%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.